Losing too much of this stuff is one problem in diabetic nephropathy.
2.
There is also evidence that AIF1 could be a diabetic nephropathy when detected in serum.
3.
Suramin decreased the progression of diabetic nephropathy-induced end-stage renal disease in rats.
4.
It may also delay progression of diabetic nephropathy and is associated with a positive clinical outcome in that regard.
5.
This includes their effects in arterial hypertension, in ventricular remodeling ( after myocardial infarction ) and possibly diabetic nephropathy.
6.
When the coagulated protease-activated protein C inhibits p66SHC a cytoprotective effect on diabetic nephropathy is placed on the kidneys.
7.
Epidemiological and clinical studies have shown ACE inhibitors reduce the progress of diabetic nephropathy independently from their blood pressure-lowering effect.
8.
Damage to nerve cells may cause peripheral neuropathy, and to kidney cells, diabetic nephropathy ( Kimmelstiel-Wilson syndrome ).
9.
There is evidence that taurine may exert a beneficial effect in preventing diabetes-associated microangiopathy and tubulointerstitial injury in diabetic nephropathy.
10.
Diabetic nephropathy is the most common cause of end-stage kidney disease, which may require hemodialysis or even kidney transplantation.